Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Response to Dr. Bernard D. Goldstein's Letter to the Editor.

Mundt KA, Gallagher AE, Dell LD, Natelson EA, Boffetta P, Gentry PR.

Crit Rev Toxicol. 2018 May;48(5):341-343. doi: 10.1080/10408444.2018.1431765. Epub 2018 Feb 20. No abstract available.

PMID:
29460663
2.

Formaldehyde, Hematotoxicity, and Chromosomal Changes-Letter.

Mundt KA, Gallagher AE, Dell LD, Natelson E, Boffetta P, Gentry PR.

Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):119. doi: 10.1158/1055-9965.EPI-17-0306. No abstract available.

3.

Does occupational exposure to formaldehyde cause hematotoxicity and leukemia-specific chromosome changes in cultured myeloid progenitor cells?

Mundt KA, Gallagher AE, Dell LD, Natelson EA, Boffetta P, Gentry PR.

Crit Rev Toxicol. 2017 Aug;47(7):592-602. doi: 10.1080/10408444.2017.1301878. Epub 2017 May 2. Review. Erratum in: Crit Rev Toxicol. 2017 Aug;47(7):i.

PMID:
28462599
4.

Skepticism, the Trained Eye, and the Telltale Clue.

Natelson EA.

Tex Heart Inst J. 2016 Jun 1;43(3):205-6. doi: 10.14503/THIJ-15-5612. eCollection 2016 Jun. No abstract available.

5.

Successful long-term treatment of Philadelphia chromosome-negative myeloproliferative neoplasms with combination of hydroxyurea and anagrelide.

Ahn IE, Natelson E, Rice L.

Clin Lymphoma Myeloma Leuk. 2013 Sep;13 Suppl 2:S300-4. doi: 10.1016/j.clml.2013.05.015.

PMID:
24290215
6.

Acquired myelodysplasia or myelodysplastic syndrome: clearing the fog.

Natelson EA, Pyatt D.

Adv Hematol. 2013;2013:309637. doi: 10.1155/2013/309637. Epub 2013 Oct 7. Review.

7.

Extreme thrombocytosis and cardiovascular surgery: risks and management.

Natelson EA.

Tex Heart Inst J. 2012;39(6):792-8. Review.

8.

Temozolomide-induced myelodysplasia.

Natelson EA, Pyatt D.

Adv Hematol. 2010;2010:760402. doi: 10.1155/2010/760402. Epub 2010 Mar 4.

9.

Is inhalation exposure to formaldehyde a biologically plausible cause of lymphohematopoietic malignancies?

Pyatt D, Natelson E, Golden R.

Regul Toxicol Pharmacol. 2008 Jun;51(1):119-33. doi: 10.1016/j.yrtph.2008.03.003. Epub 2008 Mar 18. Review.

PMID:
18440686
10.

Benzene exposure and refractory sideroblastic erythropoiesis: is there an association?

Natelson EA.

Am J Med Sci. 2007 Nov;334(5):356-60. Review.

PMID:
18004090
11.

Benzene-induced acute myeloid leukemia: a clinician's perspective.

Natelson EA.

Am J Hematol. 2007 Sep;82(9):826-30. Review.

12.
13.
14.

Atypical mycobacterial infection in a patient with hairy cell leukemia.

Trizna Z, Tschen J, Natelson EA.

Cutis. 2001 Mar;67(3):241-2.

PMID:
11270299
15.

A study of 9-nitrocamptothecin (RFS-2000) in patients with advanced pancreatic cancer.

Stehlin JS, Giovanella BC, Natelson EA, De Ipolyi PD, Coil D, Davis B, Wolk D, Wallace P, Trojacek A.

Int J Oncol. 1999 May;14(5):821-31.

PMID:
10200331
16.

Multiple subcutaneous nodules on the torso and leg. Leukemia cutis.

Trizna Z, Tschen J, Natelson EA.

Arch Dermatol. 1998 Nov;134(11):1479, 1482. No abstract available.

PMID:
9828890
17.

A phase I clinical and pharmacological study of oral 9-nitrocamptothecin, a novel water-insoluble topoisomerase I inhibitor.

Verschraegen CF, Natelson EA, Giovanella BC, Kavanagh JJ, Kudelka AP, Freedman RS, Edwards CL, Ende K, Stehlin JS.

Anticancer Drugs. 1998 Jan;9(1):36-44.

PMID:
9491790
18.

Phase I clinical and pharmacological studies of 20-(S)-camptothecin and 20-(S)-9-nitrocamptothecin as anticancer agents.

Natelson EA, Giovanella BC, Verschraegen CF, Fehir KM, De Ipolyi PD, Harris N, Stehlin JS.

Ann N Y Acad Sci. 1996 Dec 13;803:224-30.

PMID:
8993516
19.

Protocols for the treatment of human tumor xenografts with camptothecins.

Giovanella BC, Natelson E, Harris N, Vardeman D, Stehlin JS.

Ann N Y Acad Sci. 1996 Dec 13;803:181-7. Review.

PMID:
8993511
20.

Photophobia and thickened eyelids in a healthy-appearing nurse.

Tschen LF, Tschen JA, Natelson EA, Fred HL.

Hosp Pract (1995). 1996 Feb 15;31(2):73-4. No abstract available.

PMID:
8592020
21.

L-homoserine hydroxamic acid as an antitumor agent.

Natelson S, Pantazis P, Natelson EA.

Clin Chim Acta. 1994 Sep;229(1-2):133-45.

PMID:
7988043
22.
23.

Fever, leukocytosis, and an enlarging flank mass.

Natelson EA, Fred HL.

Hosp Pract (Off Ed). 1994 Apr 15;29(4):33-4. No abstract available.

PMID:
8144724
24.

9-Nitro-camptothecin delays growth of U-937 leukemia tumors in nude mice and is cytotoxic or cytostatic for human myelomonocytic leukemia lines in vitro.

Pantazis P, Mendoza JT, Early JA, Kozielski AJ, Natelson EA, Giovanella BC.

Eur J Haematol. 1993 Feb;50(2):81-9.

PMID:
8440362
25.

Recurrent thrombotic thrombocytopenic purpura in early pregnancy: effect of uterine evacuation.

Natelson EA, White D.

Obstet Gynecol. 1985 Sep;66(3 Suppl):54S-56S.

PMID:
4040623
26.

Effects of apalcillin on platelet function in normal volunteers.

Gentry LO, Wood BA, Natelson EA.

Antimicrob Agents Chemother. 1985 May;27(5):683-4.

27.

Hereditary hemorrhagic telangiectasia and factor VIII inhibitor.

Sudarshan A, Natelson EA, Gordon C.

South Med J. 1985 May;78(5):623-4.

PMID:
3922057
28.

Human blood coagulation: clinical and laboratory correlation.

Natelson EA.

Clin Physiol Biochem. 1983;1(2-5):214-24. No abstract available.

PMID:
6680898
29.

Effects of sodium piperacillin on platelet function in normal volunteers.

Gentry LO, Jemsek JG, Natelson EA.

Antimicrob Agents Chemother. 1981 Apr;19(4):532-3.

30.

Agranulocytosis during combined procainamide and phenytoin therapy.

Crook JE, Woosley RL, Leftwich RB, Natelson EA.

South Med J. 1979 Dec;72(12):1599-601.

PMID:
515773
31.

Combined effects of ticarcillin and cefazolin on blood coagulation and platelet function.

Natelson EA, Siebert WT, Williams TW, Bradshaw MW.

Am J Med Sci. 1979 Nov-Dec;278(3):217-21.

PMID:
539599
32.

Gaucher's disease in a black adult.

Novy SB, Natelson E, Stuart L, Whitlock L.

AJR Am J Roentgenol. 1979 Nov;133(5):947-9. No abstract available.

PMID:
115292
33.

A rheological study of the kinetics of coagulation in normal and hemophilic blood plasma.

Kuntamukkula MS, McIntire LV, Natelson EA.

Biorheology. 1979;16(6):403-10. No abstract available.

PMID:
534763
34.

Thrombocytopenic purpura--idiopathic and thrombotic.

Zeluff GW, Natelson EA, Jackson D.

Heart Lung. 1978 Mar-Apr;7(2):327-33. No abstract available.

PMID:
246028
35.

Grossly bloody urine of runners.

Fred HL, Natelson EA.

South Med J. 1977 Dec;70(12):1394-6.

PMID:
594787
36.

Inhibition of ristocetin-induced platelet agglutination by vancomycin.

Moake JL, Cimo PL, Peterson DM, Roper P, Natelson EA.

Blood. 1977 Sep;50(3):397-406.

37.

Progressive swelling of abdomen and lower extremities with abnormal chest roentgenogram.

Fred HL, Blakely RW, Natelson EA.

Chest. 1977 Mar;71(3):381-2. No abstract available.

PMID:
837752
38.

Mechanical trauma effect on clot structure formation.

Glover CJ, McIntire LV, Brown CH 3rd, Natelson EA.

Thromb Res. 1977 Jan;10(1):11-25. No abstract available.

PMID:
850895
39.
40.

Lead poisoning from cocktail glasses. Observations on two patients.

Natelson EA, Fred HL.

JAMA. 1976 Nov 29;236(22):2527. No abstract available.

PMID:
1036519
41.

A simple method of intraoperative autotransfusion.

Noon GP, Solis RT, Natelson EA.

Surg Gynecol Obstet. 1976 Jul;143(1):65-70.

PMID:
936052
42.

Defective platelet function following the administration of penicillin compounds.

Brown CH 3rd, Bradshaw MJ, Natelson EA, Alfrey CP Jr, Williams TW Jr.

Blood. 1976 Jun;47(6):949-56.

43.

Chronic consumption coagulopathy accompanying abdominal aortic aneurysm.

Siebert WT, Natelson EA.

Arch Surg. 1976 May;111(5):539-41.

PMID:
1083726
44.

Thrombotic thrombocytopenic purpura occurring despite absence of the spleen: report of case.

Shapiro DM, Zeluff GW, Wilson K, Natelson EA, Lynch EC.

J Am Osteopath Assoc. 1976 May;75(9):798-802. No abstract available.

PMID:
1046437
45.

Influence of cephalosporin antibiotics on blood coagulation and platelet function.

Natelson EA, Brown CH 3rd, Bradshaw MW, Alfrey CP Jr, Williams TW Jr.

Antimicrob Agents Chemother. 1976 Jan;9(1):91-3.

46.

Absent factor II in systemic lupus erythematosus. Immunologic studies and response to corticosteroid therapy.

Natelson EA, Cyprus GS, Hettig RA.

Arthritis Rheum. 1976 Jan-Feb;19(1):79-82.

PMID:
814906
47.

Rheological properties of fibrin clots. Effects of fibrinogen concentration, Factor XIII deficiency, and Factor XIII inhibition.

Glover CJ, McIntire LV, Brown CH 3rd, Natelson EA.

J Lab Clin Med. 1975 Oct;86(4):644-56.

PMID:
1176815
48.

Dynamic coagulation studies: influence of normal and abnormal platelets on clot structure formation.

Glover CJ, McIntire LV, Brown CH 3rd, Natelson EA.

Thromb Res. 1975 Jul;7(1):185-98. No abstract available.

PMID:
1154337
49.

Detection of mild factor VIII Deficiency by thrombokinetics.

Natelson EA, Shapiro D, Smith DF.

Am J Clin Pathol. 1975 Jul;64(1):95-100.

PMID:
1155379
50.

Factor IX deficiency in the nephrotic syndrome: studies with prothrombin complex concentrate.

Rahman F, Zanger B, Natelson EA.

J Urol. 1975 Jun;113(6):853-5.

PMID:
1152161

Supplemental Content

Loading ...
Support Center